Company’s Liver Cancer Drug Candidate IP Portfolio strengthened Company provides operational...
Read More ...
NEW YORK, February 10, 2023 - Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial...
Company converts future royalty into 15% equity in multi-billion dollar potential product...
CORPORATE PRESENTATION
FACT SHEET
